Gastrointestinal System Disorders Q 125 - Gyan Darpan : Learning Portal
Get GK Updates on WhatsApp

Post Top Ad

Thursday, 14 April 2022

Gastrointestinal System Disorders Q 125

A client is to take one daily dose of ranitidine (Zantac) at home to treat her peptic ulcer. The nurse knows that the client understands proper drug administration of ranitidine when she says that she will take the drug at which of the following times?
    A. Before meals
    B. With meals
    C. At bedtime
    D. When pain occurs

Correct Answer: C. At bedtime

Ranitidine blocks the secretion of hydrochloric acid. Clients who take only one daily dose of ranitidine are usually advised to take it at bedtime to inhibit the nocturnal secretion of acid. Clients who take the drug twice a day are advised to take it in the morning and at bedtime. Ranitidine’s acid-lowering effect is more pronounced for basal and nocturnal acid secretion than it is for food-stimulated acid secretion.

Option A: Ranitidine is available as tablets, capsules, or oral syrup. Ranitidine solution or the dissolved tablet may be mixed with select enteral tube feeding solutions. When dosed orally, ranitidine has a bioavailability of 50%, which is relatively unaffected by food. The peak levels occur 2 to 3 hours post-administration for oral administration and occur 15 minutes after intramuscular administration.
Option B: Ranitidine is a competitive inhibitor of histamine H2-receptors. The reversible inhibition of the H2-receptors in gastric parietal cells results in a reduction in both gastric acid volume and concentration. Ranitidine is primarily excreted unchanged in the urine, with a half-life ranging from 2.5 to 3 hours, and because of the renal elimination, the half-life may increase to 4 to 5 hours in patients with kidney dysfunction.
Option D: Clinicians urge patients to seek professional medical care and contraindicate the over-the-counter product when they have difficulty or pain when swallowing food or have blood in vomit or stool. Concurrent use is contraindicated with other acid reducers, kidney disease, or in patients younger than 12 years old.

No comments:

Post a Comment

Post Top Ad